KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Inventory Average (2016 - 2025)

Acadia Pharmaceuticals has reported Inventory Average over the past 10 years, most recently at $31.9 million for Q4 2025.

  • Quarterly results put Inventory Average at $31.9 million for Q4 2025, down 23.16% from a year ago — trailing twelve months through Dec 2025 was $31.9 million (down 23.16% YoY), and the annual figure for FY2025 was $28.3 million, down 1.99%.
  • Inventory Average for Q4 2025 was $31.9 million at Acadia Pharmaceuticals, up from $27.6 million in the prior quarter.
  • Over the last five years, Inventory Average for ACAD hit a ceiling of $66.7 million in Q2 2024 and a floor of $6.1 million in Q3 2022.
  • Median Inventory Average over the past 5 years was $13.8 million (2021), compared with a mean of $22.9 million.
  • Biggest five-year swings in Inventory Average: soared 772.64% in 2024 and later tumbled 63.23% in 2025.
  • Acadia Pharmaceuticals' Inventory Average stood at $11.1 million in 2021, then crashed by 43.83% to $6.2 million in 2022, then skyrocketed by 353.42% to $28.3 million in 2023, then skyrocketed by 46.66% to $41.5 million in 2024, then fell by 23.16% to $31.9 million in 2025.
  • The last three reported values for Inventory Average were $31.9 million (Q4 2025), $27.6 million (Q3 2025), and $24.5 million (Q2 2025) per Business Quant data.